Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

The Impact of COVID-19 on the Nursing Profession in the U.S.

The Impact of COVID-19 on the Nursing Profession in the U.S.

A 2020 Quantitative Survey Summary Commissioned by Johnson & Johnson, the American Nurses Association (ANA) and American Organization for Nursing Leadership (AONL).

Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that vaccinations with the Company’s COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization (EUA), following a decision from the United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA).

Washington University looking for children for COVID-19 vaccine trial

Washington University in St. Louis has been chosen to start two vaccine trials for children. One trial will be for the Moderna vaccine in children 12 years old and under. The other trial will be with Johnson & Johnson. It will test the vaccine in children from birth to 17 years old. The hospital plans to … Continued

Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company’s COVID-19 Vaccine Candidate

Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into an agreement with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate to African Union‘s 55 member states with delivery beginning in the third quarter of 2021. AVAT … Continued

J&J developing several next-generation COVID-19 vaccines, says CEO

Johnson & Johnson is developing several next generation COVID-19 vaccines against the emerging variants of the coronavirus, Chief Executive Officer Alex Gorsky said on Thursday. The drugmaker, which won the U.S. emergency use authorization of a one-shot vaccine last month, had previously said it was developing a second-generation vaccine that would target the variant first … Continued

Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate

Johnson & Johnson announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL) to the World Health Organization (WHO) for the investigational single-dose Janssen COVID-19 vaccine candidate. The data package delivered today includes interim efficacy and safety results from the Phase 3 ENSEMBLE clinical trial. The Company’s rolling submission of clinical data to … Continued

Why People of All Colors and Ages Are Crucial to Vaccine Clinical Trials [VIDEO]

Experts explain why recruiting clinical trial participants from diverse backgrounds around the world—young, old, Black, brown, Indigenous and more—is critical to developing a potential COVID-19 vaccine, in this bonus clip from “The Road to a Vaccine.”

J&J CEO says people may need annual Covid vaccine shots for the next several years

People may need to get vaccinated against Covid-19 annually, just like seasonal flu shots, over the next several years, Johnson & Johnson CEO Alex Gorsky told CNBC on Tuesday. “Unfortunately, as [the virus] spreads it can also mutate‚” he told CNBC’s Meg Tirrell during a Healthy Returns Spotlight event. “Every time it mutates, it’s almost … Continued

Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate

February 4, 2021 – Johnson & Johnson today announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its investigational single-dose Janssen COVID-19 vaccine candidate. Johnson & Johnson intends to distribute vaccine to the U.S. government immediately following authorization, and expects to supply 100 … Continued

Vanderbilt researcher breaks down Johnson & Johnson COVID-19 vaccine [VIDEO]

By the end of the week, drug maker Johnson and Johnson is expected submit its COVID-19 vaccine to the FDA for emergency use authorization.